- Home
- CATX vs DIAX Comparison
CATX vs DIAX Comparison
Compare CATX & DIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.24
Company Overview
Basic Information| Metric | CATX | DIAX |
|---|---|---|
| Founded | 1983 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.9M | 525.1M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | CATX | DIAX |
|---|---|---|
| Price | $4.24 | $14.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $12.11 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 76.3K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.93% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.75 | $13.01 |
| 52 Week High | $6.16 | $15.85 |
Technical Indicators
Market Signals| Indicator | CATX | DIAX |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 30.87 |
| Support Level | $3.17 | $13.73 |
| Resistance Level | $4.64 | $14.45 |
| Average True Range (ATR) | 0.27 | 0.21 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 53.75 | 10.26 |
Price Performance
Historical Comparison CATX
DIAX
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About DIAX Nuveen Dow 30SM Dynamic Overwrite Fund of Beneficial Interest
Nuveen Dow 30sm Dynamic Overwrite Fund is a non-diversified closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the S&P 500 Index.